Truist Securities analyst Robyn Karnauskas reiterates Merck & Co (NYSE:MRK) with a Buy and raises the price target from $139 to $142.
Truist Securities Reiterates Buy on Merck & Co, Raises Price Target to $142
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.